FORVIA FURTHER IMPROVES ITS DEBT PROFILE BY USING PROCEEDS FROM AN ADDITIONAL ISSUANCE OF SENIOR NOTES DUE 2030 AND AVAILABLE CASH TO REPURCHASE EXISTING 2027 SUSTAINABILITY-LINKED NOTES
Not for distribution, directly or indirectly, in the United States, Canada, Australia or Japan.
New Podcast Radical Cooperation Explores How Collaboration Can Reinvent Higher Education
Hosted by Dr. Michael Horowitz, the podcast will feature candid conversations with higher education leaders on tackling the sector's biggest challenges through innovative partnerships
1inch Launches New Core Algorithm, Improving Swap Rates by Up to 6.5%
DUBAI, United Arab Emirates, June 11, 2025 ( GLOBE NEWSWIRE ) -- 1inch, a leading DeFi aggregator that connects users to the best trading rates across multiple blockchains, has unveiled a new version of its price route discovery algorithm, Pathfinder.
Stitch Fix Delivers Revenue Growth: Subscriber Comeback? - Stitch Fix ( NASDAQ:SFIX )
Stitch Fix beat Q3 revenue and EPS estimates, raised FY25 outlook, and showed signs of improving client trends. Despite gains, SFIX stock slipped as macro headwinds and subscriber growth uncertainty weighed on investor sentiment.
Intel ( INTC ) Stock Is Falling Wednesday: What's Going On? - Intel ( NASDAQ:INTC )
Intel stock gained Tuesday on broad tech sector optimism, despite its own recent, weak fundamentals. Shares are pulling back Wednesday as investors refocus on the chipmaker's difficult turnaround plan. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
William Blair Bullish On Harrow's High-Margin Branded Eye Drug Strategy - Harrow ( NASDAQ:HROW )
BYQLOVI is the first new ophthalmic steroid in its class in over 15 years, with a US launch expected in Q4 2025. William Blair projects peak sales of $355 million for Vevye by 2030 and $300 million for Triesence and Iheezo by 2035. Get access to the leaderboards pointing to tomorrow's biggest ...
Gate Marks 12 Years in Crypto With 'Evolving Vision'
The crypto exchange is celebrating its 12th anniversary with a sweeping brand transformation and pushes into AI and RWAs.
What's Going On With GameStop Stock Wednesday? - GameStop ( NYSE:GME )
GameStop reports mixed results for the first quarter as total revenue falls about 17% year-over-year. Wedbush analyst Michael Pachter reiterates GameStop with an Underperform rating and price target of $13.50. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to ...
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial - Novavax ( NASDAQ:NVAX )
Novavax's combo and standalone flu shots triggered a 2.4-5.7x rise in immune response over baseline in seniors. Over 98% of adverse events were mild or moderate in Novavax's Phase 3 trial of 2,000 adults aged 65+. Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings-Live With Chris Capre ...
